MAPT and Alzheimer disease: Moreover, postmortem studies that have evaluated the brains of diabetic patients have shown increased amyloid-β (Aβ) deposition and hyperphosphorylated tau compared with that in age-matched controls3, 4, and the brains of patients with AD and diabetes exhibit increased AD pathological changes compared with the brains of non-diabetic AD patients5.